Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jimmy C. Menjivar"'
Autor:
William H Yong, Maryam Shabihkhani, Donatello Telesca, Shuai Yang, Jonathan L Tso, Jimmy C Menjivar, Bowen Wei, Gregory M Lucey, Sergey Mareninov, Zugen Chen, Linda M Liau, Albert Lai, Stanley F Nelson, Timothy F Cloughesy, Cho-Lea Tso
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141334 (2015)
Glioblastoma stem cells (GSC) co-exhibiting a tumor-initiating capacity and a radio-chemoresistant phenotype, are a compelling cell model for explaining tumor recurrence. We have previously characterized patient-derived, treatment-resistant GSC clone
Externí odkaz:
https://doaj.org/article/61762d4219e64baaadeb0dfddfffe071
Autor:
Fei Ye, Yibei Zhang, Yue Liu, Kazunari Yamada, Jonathan L Tso, Jimmy C Menjivar, Jane Y Tian, William H Yong, Dörthe Schaue, Paul S Mischel, Timothy F Cloughesy, Stanley F Nelson, Linda M Liau, William McBride, Cho-Lea Tso
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80397 (2013)
Glioblastoma stem cells (GSC) are a significant cell model for explaining brain tumor recurrence. However, mechanisms underlying their radiochemoresistance remain obscure. Here we show that most clonogenic cells in GSC cultures are sensitive to radia
Externí odkaz:
https://doaj.org/article/a036ccf297544e5ebd3010afa96febf1
Autor:
Shuai Yang, Yibei Zhang, Linda M. Liau, Albert Lai, Cho-Lea Tso, Yvonne Bui, Timothy F. Cloughesy, Alexandra Stream, Jonathan L. Tso, Kazunari Yamada, William H. Yong, Stanley F. Nelson, Irene Hong, Jimmy C. Menjivar, William H. McBride
Publikováno v:
Molecular cancer, vol 14, iss 1
Molecular Cancer
Molecular Cancer
Background Temozolomide (TMZ) is an oral DNA-alkylating agent used for treating patients with glioblastoma. However, therapeutic benefits of TMZ can be compromised by the expression of O6-methylguanine methyltransferase (MGMT) in tumor tissue. Here w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f3c22f3bb5bc4d0013c8493c4bbf422
https://escholarship.org/uc/item/5gz2p89z
https://escholarship.org/uc/item/5gz2p89z
Autor:
Shuai Yang, Stanley F. Nelson, Jonathan L. Tso, Jimmy C. Menjivar, William H. Yong, Maryam Shabihkhani, Bowen Wei, Sergey Mareninov, Linda M. Liau, Cho-Lea Tso, Gregory M. Lucey, Timothy F. Cloughesy, Albert Lai, Zugen Chen, Donatello Telesca
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141334 (2015)
PloS one, vol 10, iss 10
PLoS ONE
PloS one, vol 10, iss 10
PLoS ONE
Glioblastoma stem cells (GSC) co-exhibiting a tumor-initiating capacity and a radio-chemoresistant phenotype, are a compelling cell model for explaining tumor recurrence. We have previously characterized patient-derived, treatment-resistant GSC clone
Autor:
Timothy F. Cloughesy, William H. Yong, Dörthe Schaue, Jane Y. Tian, Fei Ye, William H. McBride, Linda M. Liau, Jonathan L. Tso, Stanley F. Nelson, Yue Liu, Jimmy C. Menjivar, Kazunari Yamada, Paul S. Mischel, Yibei Zhang, Cho-Lea Tso
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 11, p e80397 (2013)
PloS one, vol 8, iss 11
PLoS ONE, Vol 8, Iss 11, p e80397 (2013)
PloS one, vol 8, iss 11
Glioblastoma stem cells (GSC) are a significant cell model for explaining brain tumor recurrence. However, mechanisms underlying their radiochemoresistance remain obscure. Here we show that most clonogenic cells in GSC cultures are sensitive to radia
Autor:
Jonathan L. Tso, Yue Liu, Jane Tian, Cho-Lea Tso, Jimmy C. Menjivar, Linda M. Liau, William H. McBride, William H. Yong, Yibei Zhang
Publikováno v:
Cancer Research. 73:3727-3727
Glioblastoma remain resistant to radiotherapy (RT) and chemotherapy. To elucidate the cellular and molecular basis of glioblastoma resistance to standard treatment, we isolated and characterized cellular and molecular properties of glioblastoma stem
Autor:
Yue Liu, Jimmy C. Menjivar, Linda M. Liau, Yibei Zhang, William H. McBride, Cho-Lea Tso, Jane Y. Tian, Jonathan L. Tso
Publikováno v:
Cancer Research. 73:3765-3765
Glioblastoma is incurable. Glioblastoma stem cells (GSC) became a model for explaining tumor recurrence due to their tumorigenic capacity, migratory nature, and radio-chemoresistant phenotype. To prevent tumor recurrence, a strategy targeting of GSC